Elevation in S-Adenosylhomocysteine and DNA hypomethylation: Potential epigenetic mechanism for homocysteine-related pathology

Journal of Nutrition

Volumn 132, Issue 8 SUPPL., 2002, Pages

  Jill James, S ^a,b   Melnyk, Stepan ^a   Pogribna, Marta ^a   Pogribny, Igor P ^a   Caudill, Marie A ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

Author keywords

DNA methylation; Homocysteine; S adenosylhomocysteine; S adenosylmethionine

Indexed keywords

ADENOSYLHOMOCYSTEINASE; CHOLINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; METHYLTRANSFERASE; PYRIDOXINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; VITAMIN B GROUP;

BIRTH DEFECT; CHROMATIN STRUCTURE; CONFERENCE PAPER; DEMENTIA; DNA METHYLATION; ENZYME MECHANISM; GENE EXPRESSION; GENETIC POLYMORPHISM; HEART DISEASE; HOMEOSTASIS; NUTRITIONAL DEFICIENCY; PATHOGENESIS;

ANIMALS; CHRONIC DISEASE; DNA METHYLATION; HOMOCYSTEINE; HUMANS; S-ADENOSYLHOMOCYSTEINE;

EID: 0036326660     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (72)

1. Pathways and regulation of homocysteine metabolism in mammals
2. The mechanism of action of S-adenosylhomocysteinase
3. The metabolism of homocysteine: Pathways and regulation
4. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation
5. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement
6. Nutrition, genetics, and risks of cancer
7. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease
8. The methylenetetrahydrofolate reductase 677C→T polymorphism and distal colorectal adenoma risk
9. Neural tube defects, vitamins and homocysteine
10. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase (MTHFR) gene may be maternal risk factors for Down syndrome
11. The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss
12. Demyelination and inborn errors of the single carbon transfer pathway
13. Methylenetetrahydrofolate reductase variant and schizophrenia/depression
14. Folate, vitamin B12, and neuropsychiatric disorders
15. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: The Hordaland Homocysteine Study
16. The controversy over homocysteine and cardiovascular risk
17. S-Adenosylmethionine and S-adenosylhomocysteine metabolism in isolated liver
18. Crystal structure of S-adenosylhomocysteine from rat liver
19. Selection and characterization of a murine lymphoid cell line partially deficient in S-adenosylhomocysteine hydrolase
20. Effect of adenosine metabolites on methyltransferase reactions in isolated rat livers
21. S-Adenosylmethionine-dependent methyltransferases
22. Resistance to inhibitors of S-adenosyl-L-homocysteine hydrolase in C1300 murine neuroblastoma tumor cells is associated with increased methionine adenosyltransferase activity
23. S-Adenosylmethionine synthetase is overexpressed in murine neuroblastoma cells resistant to nucleoside analogue inhibitors of S-adenosylhomocysteine hydrolase: A novel mechanism of drug resistance
24. The role of S-adenosylhomocysteine in the biological utilization of S-adenosylmethionine
25. Relationship between tissue levels of S-adenosylmethionine, S-adenosylhomocysteine, and transmethylation reactions
26. The effect of S-adenosylhomocysteine on the DNA methylation in isolated rat liver nuclei
27. Molecular and cytological evidence of S-adenosyl-L-homocysteine as an innocuous under-methylating agent in vivo
28. Decreased transmethylation of biogenic amines after in vivo elevation of brain S-adenosyl-L-homocysteine
29. Microsomal phosphatidylethanolamine methyltransferase: Inhibition by S-adenosylhomocysteine
30. S-Adenosylhomocysteine inhibition of three purified tRNA methyltransferases from rat liver
31. Effects of S-adenosylhomocysteine analogues on vaccinia viral messenger ribonucleic acid synthesis and ethylation
32. Inhibition of transmethylation of biogenic mines by S-adenosylhomocysteine
33. Affinity labeling of histamine N-methyltransferase by 2′,3′-dialdehyde derivatives of S-adenosylhomocysteine and S-adenosylmethionine: Kinetics of inactivation
34. Effects of the disruption of transmethylation in the central nervous system: An animal model
35. The relationship between the activity of methionine synthase and the ratio of S-adenosylmethionine to S-adenosylhomocysteine in the brain and other tissues of the pig
36. The action of the adenosylhomocysteine hydrolase inhibitor, 3-deazaadenosine, on phagocytic function of mouse macrophages and human monocytes
37. Phospholipids biosynthesis by methylations and choline incorporation: Effect of 3-deazaadenosine
38. Perturbation of biochemical transmethylations by 3-deazaadenosine in vivo
39. Signal transduction pathways that regulate cell survival and cell death
40. Biological effects of inhibitors of S-adenosylhomocysteine hydrolase
41. Alterations in expression and methylation of specific genes in livers of rats fed a cancer promoting methyl-deficient diet
42. Alterations in hepatic p53 gene methylation patterns during tumor progression with folate/methyl deficiency in the rat
43. Induction of HL-60 cell differentiation by 3-deaza-(∀)-aristeromycin, an inhibitor of S-adenosylhomocysteine hydrolase
44. Conversion of 3T3-L1 fibroblasts to fat cells by an inhibitor of methylation: Effect of 3-deazaadenosine
45. Basis for resistance to 3-deazaaristeromycin, an inhibitor of S-adenosylhomocysteine hydrolase, in human lymphocytes
46. Homocysteine metabolism in cardiovascular cells and tissues: Implications for hyperhomocysteinemia and cardiovascular disease
47. ras methylation in vascular endothelial cells by homocysteine but not cysteine
48. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine
49. Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease
50. Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia
51. Plasma proteins containing damaged L-aspartyl residues are increased in uremia: Implications for mechanism
52. Impaired methionine metabolism in patients undergoing colorectal carcinogenesis surgery: A pilot study in Spain
53. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine β-synthase heterozygous mice
54. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine β-synthase-deficient mice
55. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition
56. Pancreatic exocrine secretion is blocked by inhibitors of methylation
57. Correlation of the ratio of S-adenosylmethionine to S-adenosylhomocysteine in the brain and cerebro-spinal fluid of the pig: Implications for the determination of this methylation ratio in human brain
58. Roles of homocysteine in cell metabolism
59. Homocysteine
60. Transcriptional repression by the methyl CpG-binding protein MeCP2 involves a histone deacetylase complex
61. Hypomethylation of human heterochromatin detected by restriction enzyme nick translation
62. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl deficient rats
63. Accumulation of DNA strand breaks and methotrexate cytotoxicity
64. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity
65. S-Adenosylhomocysteine as physiological modulator of Apo-1-mediated apoptosis
66. Apoptosis and proliferation under conditions of deoxynucleotide pool imbalance in liver of folate/methyl deficient rats
67. Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation
68. Reactive oxygen species and death: Oxidative DNA damage in atherosclerosis
69. DNA strand breaks in Alzheimer's disease
70. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women
71. Effect of controlled folate intake on DNA methylation status in post-menopausal women
72. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene